• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis.

作者信息

Sakata Shinya, Matsuoka Yuichiro, Kawahara Kenta, Kakiuchi Yosuke, Takaki Akira, Hirosue Akiyuki, Yoshida Ryoji, Saeki Sho, Fujii Kazuhiko, Nakayama Hideki

机构信息

Department of Respiratory Medicine, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan.

Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan.

出版信息

Respir Investig. 2018 Mar;56(2):195-198. doi: 10.1016/j.resinv.2017.11.006. Epub 2017 Dec 21.

DOI:10.1016/j.resinv.2017.11.006
PMID:29548660
Abstract

A 70-year-old Japanese man with recurrent squamous cell carcinoma of the head and neck presented with severe interstitial pneumonia associated with nivolumab, after talc slurry pleurodesis. Following the development of malignant pleural effusion, he underwent chest drainage and was administered intrathoracic talc as a pleurodesis. Two weeks later, we administered nivolumab (3mg/kg) to be repeated every 2 weeks. However, on day 12, chest computed tomography scan demonstrated diffuse non-segmental ground-glass opacity and mild bronchiectasis. We diagnosed interstitial pneumonia associated with nivolumab. Although corticosteroid pulse therapy was initiated, the patient died of respiratory failure on day 14.

摘要

相似文献

1
Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis.
Respir Investig. 2018 Mar;56(2):195-198. doi: 10.1016/j.resinv.2017.11.006. Epub 2017 Dec 21.
2
Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer.纳武利尤单抗相关的间质性肺病分析:两项复发或晚期非小细胞肺癌患者的 II 期研究。
Lung Cancer. 2017 Feb;104:111-118. doi: 10.1016/j.lungcan.2016.12.016. Epub 2016 Dec 21.
3
Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.滑石粉喷洒术与滑石粉浆治疗恶性胸腔积液的前瞻性对照研究。
Eur J Cardiothorac Surg. 2006 Dec;30(6):827-32. doi: 10.1016/j.ejcts.2006.10.002.
4
Talc-induced interstitial pneumonitis with respiratory failure.滑石粉所致间质性肺炎伴呼吸衰竭
Anaesth Intensive Care. 2009 Jan;37(1):127-9. doi: 10.1177/0310057X0903700114.
5
Talc pleurodesis in pleuropulmonary diseases treatment.滑石粉胸膜固定术在胸膜肺部疾病治疗中的应用
Med Glas (Zenica). 2014 Aug;11(2):264-9.
6
[Talc pleurodesis in recurrent malignant pleural effusion--a prospective follow-up study].滑石粉胸膜固定术治疗复发性恶性胸腔积液——一项前瞻性随访研究
Zentralbl Chir. 1996;121(3):216-22.
7
A propensity score-matched comparison of the efficacies of OK-432 and talc slurry for pleurodesis for malignant pleural effusion induced by lung adenocarcinoma.OK-432与滑石粉悬液用于肺腺癌所致恶性胸腔积液胸膜固定术疗效的倾向评分匹配比较。
Respir Investig. 2016 Sep;54(5):341-6. doi: 10.1016/j.resinv.2016.04.005. Epub 2016 Jun 21.
8
Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?完全性胸膜固定术后肺复张是滑石粉胸膜固定术后成功预后的决定因素吗?
Chest. 2009 Aug;136(2):361-368. doi: 10.1378/chest.08-2448. Epub 2009 Apr 6.
9
[Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].[胸腔镜滑石粉胸膜固定术治疗恶性胸腔积液:27例分析]
Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Dec 18;40(6):600-2.
10
Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial.滑石粉浆胸膜固定术后短期与长期胸腔闭式引流治疗恶性胸腔积液的疗效:一项随机试验
Lung Cancer. 2006 Oct;54(1):51-5. doi: 10.1016/j.lungcan.2006.06.004. Epub 2006 Aug 21.

引用本文的文献

1
Atezolizumab-Induced Immune-Related Pneumonia on Rounded Atelectasis.阿替利珠单抗诱导的圆形肺不张相关免疫性肺炎。
Clin Respir J. 2024 Sep;18(9):e70008. doi: 10.1111/crj.70008.
2
The potential role of lung microbiota and lauroylcarnitine in T-cell activation associated with checkpoint inhibitor pneumonitis.肺微生物群和月桂酰肉碱在与检查点抑制剂性肺炎相关的 T 细胞激活中的潜在作用。
EBioMedicine. 2024 Aug;106:105267. doi: 10.1016/j.ebiom.2024.105267. Epub 2024 Aug 3.
3
Early Onset of Severe Interstitial Pneumonitis Associated With Anti-PD-1 Immune Checkpoint Antibody After Pleurodesis.
胸膜固定术后与抗PD-1免疫检查点抗体相关的严重间质性肺炎的早期发作
Cureus. 2024 Apr 23;16(4):e58798. doi: 10.7759/cureus.58798. eCollection 2024 Apr.
4
Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer.与免疫检查点抑制剂使用相关的肺部毒性:癌症支持治疗多国协会中性粒细胞减少、感染与骨髓抑制研究组免疫肿瘤学亚组的最新进展
Front Pharmacol. 2021 Oct 5;12:743582. doi: 10.3389/fphar.2021.743582. eCollection 2021.
5
Successful Re-administration of Atezolizumab for a Non-small-cell Lung Cancer Patient after Cardiac Tamponade Development as a Manifestation of Pseudo-progression Induced by Combination Treatment with Atezolizumab and Cytotoxic Chemotherapy.阿特珠单抗联合细胞毒化疗假性进展致心脏压塞后再次使用阿特珠单抗治疗非小细胞肺癌 1 例
Intern Med. 2021 Sep 15;60(18):3009-3013. doi: 10.2169/internalmedicine.6509-20. Epub 2021 Apr 5.